Company operates three super specialty hospitals located in Delhi NCR, i.e.at Noida, Greater Noida and Noida Extension, and are among top 10 hospitals by beds in NCR. Further, they have acquired a 305-bedded multi-speciality hospital in Orchha, Madhya Pradesh and now they own a total bed capacity of 1405 beds with In addition, they have 394 critical care beds. They engage 609 doctors and offer healthcare services across several specialties and super specialties. They employ advanced medical equipments and technology to provide timely, efficient and quality healthcare.
The Delhi-NCR healthcare industry is highly competitive with the presence of large private and government hospitals. The region has a large number of private hospitals (chains and standalone) some of which include Medanta Medicity– Gurugram, Apollo Indraprastha, BLK Max Super Specialty Hospital, Max Super Specialty Hospital Saket, Sir Ganga Ram Hospital, Batra Hospital, Yatharth Super Specialty Hospitals, Fortis Hospitals, Park Hospitals and Manipal Hospital. The large government hospitals include Lok Nayak Jai Prakash Narayan Hospital, Dr. Ram Manohar Lohia Hospital, GB Pant Hospital and AIIMS (All India Institute of Medical Sciences).
Strengths And Risks
+ Leading Super Speciality Hospitals in NCR: : They are among the leading top 10 super-specialty hospitals in Delhi NCR with diverse specialty and payer mix.
+ Hi-Tech Medical Technology: : They use cutting-edge medical technology and state-of-the-art equipment and facilities across healthcare services. All hospitals are accredited by the NABH Greater Noida and Noida Ext units are also accredited by NABL.
+ Quality Medical Professionals: : They attract and engage top medical talent, with staff of 3,303 individuals, which includes 609 doctors, of which 267 are consultant doctors, 178 are resident medical officers and 164 visiting doctors.
+ FInancial Performance: : Their EBITDA has grown at a CAGR of 41% from Rs 670 million in FY ‘21 to Rs 1,337 million in FY ‘23. Their net profit increased from Rs 195 million in FY ‘21 to Rs 441. million in FiY 22 which further increased to Rs 657 million in FY ‘23.
+ Experienced Management: : The are led by We are led by a family of doctors, Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar, each of whom have over 17 years of experience in the medical profession and strong management team with significant experience in the industry.
+ Insurance Empanelment: : They are empanelled with several third-party health insurance administrators, non-life insurance companies, ESIC, CGHS as well as public and private sector cos.
- High Fixed Cost: : Company operates in an industry with high fixed costs, which is continuous and does not significantly vary w.r.t. revenue generated.
- Key Personnel: : Business is dependent on a number of key personnel, including our Promoters, senior management and doctors, and the loss of or our inability to attract or retain them can adversely affect revenues.
- Regulatory Risk: : Company operates in a heavily regulated industry and are required to obtain a number of approvals and licenses from governmental and regulatory authorities. Any failure can impact the business survival.
- Subsidiary losses: : They intend to deploy a portion of the Net Proceeds towards repayment of borrowings, and capital expenditure of Ramraja which has incurred losses in the past.
FAQs What is the Yatharth Hospital & Trauma Care Services Limited IPO? +
When will the IPO open? +
What is the lot size of the IPO? +
How to apply for an IPO? +
When will the IPO be allotted? +
When is the IPO listing date? +
